• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤药物玫瑰树碱抑制大鼠肝细胞色素P450的活性。

Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450.

作者信息

Aimová Dagmar, Stiborová Marie

机构信息

Department of Biochemistry, Charles University, Albertov 2030, Prague 2, Czech Republic.

出版信息

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):437-40.

PMID:16601806
Abstract

Ellipticine is a potent antineoplastic agent, whose mode of action is considered to be based mainly on DNA intercalation and/or inhibition of topoisomerase II. Recently, we found that ellipticine also forms the cytochrome P450 (CYP)-mediated covalent DNA adducts. Here, we study the effect of ellipticine on CYP enzymes in rat hepatic microsomes, studying its binding to the enzymes and its potential to inhibit the CYP activities measured with their selective substrates. Although ellipticine was reported to be a selective and strong inhibitor of CYP1A1/2, we found that its inhibitory potential is non-specific. Ellipticine is the most potent inhibitor for CYP3A-dependent 6beta-hydroxylation of progesterone, followed by CYP1A1/2-dependent ethoxyresorufin O-deethylation and CYP2B-mediated pentoxyresorufin O-depentylation. Lower inhibition was detected for 1'-hydroxylation of bufurarol, 21-hydroxylation of progesterone and 6-hydroxylation of chlorzoxazone catalyzed by CYP2D, CYP2C and CYP2E1, respectively. Ellipticine binds to several CYPs of rat hepatic microsomes. The binding titration of ellipticine typically give reverse type I spectrum with CYPs in rat hepatic microsomes. The results indicate that inhibition of CYPs by ellipticine cannot be explained only by its differential potency to bind to individual CYPs.

摘要

椭圆玫瑰树碱是一种强效抗肿瘤药物,其作用模式被认为主要基于DNA嵌入和/或拓扑异构酶II的抑制。最近,我们发现椭圆玫瑰树碱还能形成细胞色素P450(CYP)介导的共价DNA加合物。在此,我们研究椭圆玫瑰树碱对大鼠肝微粒体中CYP酶的影响,研究其与这些酶的结合情况以及用其选择性底物测定的抑制CYP活性的潜力。尽管据报道椭圆玫瑰树碱是CYP1A1/2的选择性强抑制剂,但我们发现其抑制潜力是非特异性的。椭圆玫瑰树碱是孕酮CYP3A依赖性6β-羟基化的最有效抑制剂,其次是CYP1A1/2依赖性乙氧基亚香豆素O-脱乙基化和CYP2B介导的戊氧基亚香豆素O-脱戊基化。对于分别由CYP2D、CYP2C和CYP2E1催化的布库洛尔1'-羟基化、孕酮21-羟基化和氯唑沙宗6-羟基化,检测到的抑制作用较低。椭圆玫瑰树碱与大鼠肝微粒体的几种CYP结合。椭圆玫瑰树碱的结合滴定通常在大鼠肝微粒体中与CYP产生反向I型光谱。结果表明,椭圆玫瑰树碱对CYP的抑制作用不能仅用其与单个CYP结合的差异效力来解释。

相似文献

1
Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450.抗肿瘤药物玫瑰树碱抑制大鼠肝细胞色素P450的活性。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):437-40.
2
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.抗癌药物椭圆玫瑰树碱在肝微粒体中的氧化模式——人与大鼠系统之间的相似性
Gen Physiol Biophys. 2006 Sep;25(3):245-61.
3
Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.能将抗癌药物玫瑰树碱激活为可与DNA中的脱氧鸟苷共价结合的物质的大鼠微粒体,是模拟玫瑰树碱在人体内生物活化的合适模型。
Chem Res Toxicol. 2003 Jan;16(1):38-47. doi: 10.1021/tx0200818.
4
The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide.抗癌药物玫瑰树碱通过代谢生成13-羟基玫瑰树碱和玫瑰树碱N2-氧化物,由人细胞色素P450介导形成共价DNA加合物。
Cancer Res. 2004 Nov 15;64(22):8374-80. doi: 10.1158/0008-5472.CAN-04-2202.
5
Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.肝细胞色素P450在抗癌药物椭圆玫瑰树碱生物活化中的作用:对肝脏NADPH:细胞色素P450还原酶缺失小鼠的研究
Toxicol Appl Pharmacol. 2008 Feb 1;226(3):318-27. doi: 10.1016/j.taap.2007.09.017. Epub 2007 Sep 26.
6
Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.用NADPH:P450还原酶重构的细胞色素P450模拟微粒体中抗癌药物玫瑰树碱的活化和解毒代谢。
Neuro Endocrinol Lett. 2006 Dec;27 Suppl 2:18-22.
7
The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.抗癌药物玫瑰树碱是大鼠细胞色素P450 1A1和1A2的强效诱导剂,从而调节其自身的代谢。
Drug Metab Dispos. 2007 Oct;35(10):1926-34. doi: 10.1124/dmd.107.016048. Epub 2007 Jul 26.
8
Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.穿心莲提取物和穿心莲内酯对大鼠和人肝脏细胞色素P450的差异性抑制作用。
J Ethnopharmacol. 2008 Feb 12;115(3):432-40. doi: 10.1016/j.jep.2007.10.013. Epub 2007 Oct 22.
9
The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.鞣酸对大鼠和人肝微粒体中细胞色素P450酶及NADPH - CYP还原酶的抑制作用。
Food Chem Toxicol. 2008 Feb;46(2):645-53. doi: 10.1016/j.fct.2007.09.073. Epub 2007 Sep 15.
10
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.抗癌药物玫瑰树碱在人神经母细胞瘤细胞中产生细胞毒性及形成DNA加合物的机制
Biochem Pharmacol. 2009 May 1;77(9):1466-79. doi: 10.1016/j.bcp.2009.01.021. Epub 2009 Feb 13.

引用本文的文献

1
Cytochrome P450 family 1 inhibitors and structure-activity relationships.细胞色素 P450 家族 1 抑制剂及其结构-活性关系。
Molecules. 2013 Nov 25;18(12):14470-95. doi: 10.3390/molecules181214470.
2
Para-nitrophenol hydroxylation by fish liver microsomes: kinetics and effect of selective cytochrome P450 inhibitors.对虾肝微粒体中对硝基苯酚羟化作用的研究:动力学及选择性细胞色素 P450 抑制剂的影响。
Fish Physiol Biochem. 2011 Dec;37(4):969-76. doi: 10.1007/s10695-011-9494-z. Epub 2011 May 11.
3
Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
从β-萘黄酮处理的小鼠中鉴定新的2-氨基-3-甲基咪唑并[4,5-f]喹啉尿液代谢物。
Drug Metab Dispos. 2009 Aug;37(8):1690-7. doi: 10.1124/dmd.109.027342. Epub 2009 May 18.